People with type 1 diabetes should be warned that contact dermatitis (both irritant and allergic) may occur with all CGM devices that attach to the skin [81,82,83]
For patients with pre-existing retinopathy, monitoring and coordination with an ophthalmologist is recommended, especially during rapid improvement in glycemic control
Recent milestones in tripeptide research further underscore their therapeutic relevance
Warning signs to report are prolonged numbness, persistent pain, swelling, redness that spreads, or changes in skin colour or temperature
So entsteht ein intelligentes Netzwerk, das Deinen Krper umfassend untersttzt
These symptoms, while uncomfortable, are not typically dangerous